AFN-12520000

· Affinium Pharmaceuticals, Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AFN-12520000, covering 2012-08-07 to 2012-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci [Phase 2]

See pricing